These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 34481211)
1. Bcl-10, trypsin and synaptophysin helps recognize acinar cell and mixed acinar neuroendocrine cell carcinoma of the pancreas on both preoperative cytological samples and needle biopsy specimens. Manfrin E; Parisi A; Stefanizzi L; D'Onofrio M; Bernardoni L; Crino SF; Pelosi G; Pancione M; Giordano G; Sina S; Remo A Pathol Res Pract; 2021 Oct; 226():153593. PubMed ID: 34481211 [TBL] [Abstract][Full Text] [Related]
2. BCL10 as a useful marker for pancreatic acinar cell carcinoma, especially using endoscopic ultrasound cytology specimens. Hosoda W; Sasaki E; Murakami Y; Yamao K; Shimizu Y; Yatabe Y Pathol Int; 2013 Mar; 63(3):176-82. PubMed ID: 23530562 [TBL] [Abstract][Full Text] [Related]
3. Carboxypeptidase A1 and regenerating islet-derived 1α as new markers for pancreatic acinar cell carcinoma. Said S; Kurtin PJ; Nasr SH; Graham RP; Dasari S; Vrana JA; Yasir S; Torbenson MS; Zhang L; Mounajjed T; Eric Chen ZM; Lee HE; Wu TT Hum Pathol; 2020 Sep; 103():120-126. PubMed ID: 32702400 [TBL] [Abstract][Full Text] [Related]
4. The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia. La Rosa S; Franzi F; Marchet S; Finzi G; Clerici M; Vigetti D; Chiaravalli AM; Sessa F; Capella C Virchows Arch; 2009 Feb; 454(2):133-42. PubMed ID: 19066953 [TBL] [Abstract][Full Text] [Related]
5. The cytologic and immunohistochemical findings of pancreatic mixed acinar-endocrine carcinoma. Whitehair R; Stelow EB Diagn Cytopathol; 2021 Feb; 49(2):287-294. PubMed ID: 33128511 [TBL] [Abstract][Full Text] [Related]
6. Cytomorphologic and immunophenotypical features of acinar cell neoplasms of the pancreas. Sigel CS; Klimstra DS Cancer Cytopathol; 2013 Aug; 121(8):459-70. PubMed ID: 23408736 [TBL] [Abstract][Full Text] [Related]
7. Gastric mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) with pancreatic acinar differentiation: a case report. Fujita Y; Uesugi N; Sugimoto R; Eizuka M; Matsumoto T; Sugai T Diagn Pathol; 2019 May; 14(1):38. PubMed ID: 31077220 [TBL] [Abstract][Full Text] [Related]
8. Pancreatic mixed acinar-neuroendocrine carcinoma, a unique diagnostic challenge on FNA cytology: A small series of two cases with literature review. Strait AM; Sharma N; Tsapakos MJ; Vaickus LJ; Liu X Diagn Cytopathol; 2018 Nov; 46(11):971-976. PubMed ID: 30284406 [TBL] [Abstract][Full Text] [Related]
9. Metastatic mixed acinar-neuroendocrine carcinoma of the pancreas to the liver: a cytopathology case report with review of the literature. Lee L; Bajor-Dattilo EB; Das K Diagn Cytopathol; 2013 Feb; 41(2):164-70. PubMed ID: 22903971 [TBL] [Abstract][Full Text] [Related]
10. A case of pancreatic mixed acinar-neuroendocrine carcinoma successfully diagnosed with endoscopic ultrasound-guided fine needle aspiration. Niiya F; Takano Y; Azami T; Kobayashi T; Maruoka N; Wakabayashi T; Matsuo K; Tanaka K; Norose T; Ohike N; Nagahama M Clin J Gastroenterol; 2020 Oct; 13(5):951-958. PubMed ID: 32529486 [TBL] [Abstract][Full Text] [Related]
11. Cytological findings and BCL10 expression in pancreatic acinar cell carcinoma: A Case Report. Ohno A; Sato Y; Nakamura E; Noguchi H; Tokumitsu T; Hiyoshi M; Nanashima A; Asada Y Diagn Cytopathol; 2017 Mar; 45(3):247-251. PubMed ID: 27860444 [TBL] [Abstract][Full Text] [Related]
12. Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor. Tanigawa M; Nakayama M; Taira T; Hattori S; Mihara Y; Kondo R; Kusano H; Nakamura K; Abe Y; Ishida Y; Okabe Y; Hisaka T; Okuda K; Fujino K; Ito T; Kawahara A; Naito Y; Yamaguchi R; Akiba J; Akagi Y; Yano H Med Mol Morphol; 2018 Mar; 51(1):32-40. PubMed ID: 28849340 [TBL] [Abstract][Full Text] [Related]
13. Fine needle aspiration cytology of acinar cell carcinoma of the pancreas: a report of two cases. Samuel LH; Frierson HF Acta Cytol; 1996; 40(3):585-91. PubMed ID: 8669201 [TBL] [Abstract][Full Text] [Related]
14. Cytomorphologic, immunophenotypical and molecular features of pancreatic acinar cell carcinoma. Sun T; Gilani S; Jain D; Cai G Diagn Cytopathol; 2023 Nov; 51(11):674-683. PubMed ID: 37469257 [TBL] [Abstract][Full Text] [Related]
15. [Clinicopathologic characterisitics of pancreatic acinar cell carcinomas]. Ding XH; Wang ZB; Qiu XM Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):274-278. PubMed ID: 29690667 [No Abstract] [Full Text] [Related]
16. Solid-pseudopapillary tumor of the pancreas: immunohistochemical localization of neuroendocrine markers and CD10. Notohara K; Hamazaki S; Tsukayama C; Nakamoto S; Kawabata K; Mizobuchi K; Sakamoto K; Okada S Am J Surg Pathol; 2000 Oct; 24(10):1361-71. PubMed ID: 11023097 [TBL] [Abstract][Full Text] [Related]
17. Non-Ductal Tumors of the Pancreas. Dhillon J Monogr Clin Cytol; 2020; 26():92-108. PubMed ID: 32987393 [TBL] [Abstract][Full Text] [Related]
18. Microglandular carcinoma of the pancreas. Klimstra DS; Lonardo F Am J Clin Pathol; 1997 Jun; 107(6):711-3. PubMed ID: 9169670 [No Abstract] [Full Text] [Related]
19. The usefulness of lymphoid enhancer-binding factor 1 and androgen receptor in diagnosing solid pseudopapillary neoplasm of the pancreas on cytopathology. McHugh KE; Stelow EB; Harrison GP; Policarpio-Nicolas MLC Cancer Cytopathol; 2019 Nov; 127(11):700-707. PubMed ID: 31584754 [TBL] [Abstract][Full Text] [Related]
20. Acinar cell carcinoma of the pancreas: a clinicopathologic and cytomorphologic review. Mustafa S; Hruban RH; Ali SZ J Am Soc Cytopathol; 2020; 9(6):586-595. PubMed ID: 32461075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]